Screener
NeoGenomics NEO Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by NeoGenomics in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
The source filing: NeoGenomics’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001077183-26-000059
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| NET REVENUE | $201,656 | $181,330 | $388,328 | $349,365 |
| COST OF REVENUE | 109,778 | 104,072 | 215,586 | 198,861 |
| GROSS PROFIT | 91,878 | 77,258 | 172,742 | 150,504 |
| Operating expenses: | ||||
| General and administrative | 63,613 | 71,747 | 129,354 | 139,954 |
| Research and development | 10,761 | 9,023 | 20,295 | 19,204 |
| Sales and marketing | 27,275 | 24,075 | 51,105 | 46,758 |
| Impairment charges (Note 5) | — | 20,041 | — | 20,041 |
Item 1. Financial Statements (unaudited)
FAQ
- What is NeoGenomics's total revenue?
- NeoGenomics (NEO) reported total revenue of $201.66M in Q2 2026.
- How has NeoGenomics's total revenue changed year-over-year?
- NeoGenomics's total revenue increased by 11.2% year-over-year, from $181.33M to $201.66M.
- What is the long-term trend for NeoGenomics's total revenue?
- Over 4 years (2021 to 2025), NeoGenomics's total revenue has grown at a 10.7% compound annual growth rate (CAGR), from $484.33M to $727.33M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about NeoGenomics's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude